Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial
…, A Steffensen, F Müller, AM Dyrhol-Riise… - Annals of internal …, 2021 - acpjournals.org
Background: New treatment modalities are urgently needed for patients with COVID-19. The
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …
[HTML][HTML] Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient
…, T Mannsåker, AT Mengshoel, AM Dyrhol-Riise… - Genome biology, 2014 - Springer
Background Mycobacterium tuberculosis is characterized by a low mutation rate and a lack
of genetic recombination. Yet, the rise of extensively resistant strains paints a picture of a …
of genetic recombination. Yet, the rise of extensively resistant strains paints a picture of a …
Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement
…, S Dudman, P Aukrust, AM Dyrhol‐Riise… - Journal of internal …, 2021 - Wiley Online Library
Background A high proportion of COVID‐19 patients have cardiac involvement, even those
without known cardiac disease. Downregulation of angiotensin converting enzyme 2 (ACE2), …
without known cardiac disease. Downregulation of angiotensin converting enzyme 2 (ACE2), …
[HTML][HTML] Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
…, L Heggelund, AR Holten, AM Dyrhol-Riise - Scientific reports, 2020 - nature.com
In SARS-CoV-2 infection there is an urgent need to identify patients that will progress to
severe COVID-19 and may benefit from targeted treatment. In this study we analyzed plasma …
severe COVID-19 and may benefit from targeted treatment. In this study we analyzed plasma …
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
…, A Cavallero, AM Dyrhol-Riise… - Human molecular …, 2022 - academic.oup.com
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …
deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our …
[HTML][HTML] Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
…, TH Popperud, JC Holter, AM Dyrhol-Riise… - Journal of …, 2021 - Springer
Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …
[HTML][HTML] IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
…, JK Damås, P Aukrust, TE Mollnes, AM Dyrhol-Riise - Journal of Infection, 2015 - Elsevier
Objectives Biomarkers for diagnosis and therapy efficacy in tuberculosis (TB) are requested.
We have studied biomarkers that may differentiate between active and latent TB infection (…
We have studied biomarkers that may differentiate between active and latent TB infection (…
[HTML][HTML] Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
…, KN Henriksen, T Kåsine, AM Dyrhol-Riise… - Scientific Reports, 2021 - nature.com
The association between pulmonary sequelae and markers of disease severity, as well as
pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for …
pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for …
[HTML][HTML] Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
…, B Vestad, T Sazonova, BK Granerud, AM Dyrhol-Riise… - Critical Care, 2023 - Springer
Background Gut microbiota alterations have been reported in hospitalized COVID-19 patients,
with reduced alpha diversity and altered microbiota composition related to respiratory …
with reduced alpha diversity and altered microbiota composition related to respiratory …
High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in COVID-19
…, A Barratt-Due, AM Dyrhol-Riise… - The Journal of …, 2022 - academic.oup.com
Background Immune dysregulation is a major factor in the development of severe coronavirus
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …
